By Brendan Pierson (Reuters) -A drug compounding industry group on Monday sued the U.S. Food and Drug Administration over its...
Read moreInvesting.com — As signs emerge that demand for GLP-1 drugs is stronger than expected, many are fearing the worst for packaged-food companies,...
Read moreInvesting.com – Brazil stocks were higher after the close on Monday, as gains in the Real Estate, Basic Materials and...
Read moreInvesting.com – Canada stocks were lower after the close on Monday, as losses in the Utilities, Healthcare and IT sectors...
Read moreBy Laura Matthews NEW YORK (Reuters) – Precidian Investments launched hedged ADRs on Monday that U.S. investors can use to...
Read moreInvesting.com – U.S. stocks were lower after the close on Monday, as losses in the Utilities, Consumer Services and Consumer...
Read moreBy Dietrich Knauth NEW YORK (Reuters) -FTX received court approval of its bankruptcy plan on Monday, which will allow it...
Read more(Reuters) – Tinder-parent Match Group (NASDAQ:MTCH) on Monday named Steven Bailey as its new finance chief, effective March 1, 2025,...
Read moreAfter-Hours Stock Movers: PENN Entertainment (PENN) rose 1.5% after it said it expects third quarter 2024 Retail Operations Adjusted EBITDAR...
Read moreSKK Holdings Limited (“SKK” or the “Company”) (Nasdaq: SKK), a civil engineering service provider that specializes in subsurface utility works...
Read moreDisclaimer: WallStreetJedi.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.